---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-101333"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2024-09-19T23:59:59+00:00"
generated_at: "2026-05-31T03:41:26.175068+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals sets 2024 annual meeting for Nov 20; shareholder proposals due Sept 29

## Summary
- Annual meeting scheduled for November 20, 2024; record date October 14, 2024.
- Shareholder proposals under Rule 14a-8 must be received by September 29, 2024.
- Director nominations and other business proposals also due September 29, 2024.
- Meeting date changed by more than 30 days from 2023 anniversary, triggering new deadlines.
- Universal proxy rule compliance notice must be provided by September 29, 2024.

## SEC filing metadata
- accession: 0001104659-24-101333
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2024-09-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465924101333/0001104659-24-101333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465924101333/tm2424409d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-101333
- JSON: https://secwatch.observer/filing/0001104659-24-101333.json
- Plain text: https://secwatch.observer/filing/0001104659-24-101333.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.